FDA Investigator Joanne M Schlossin

Joanne M Schlossin has conducted inspections on 225 sites in 15 countries as of 24 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
225
Last Inspection Date:
24 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Canada, Netherlands, United States of America, France, United Kingdom of Great Britain and Northern Ireland, India, El Salvador, Czechia, Italy, Australia, China, Romania, Germany, Switzerland, Colombia
FDA Investigators that have inspected at least one site in common with Joanne M Schlossin:
Ademola O Daramola, Akbar J Zaidi, Althea A Williams, Alyssa R Favro, Amanda E Lewin, PhD, Amanda T Zick, Andrea A Branche, Andrew B Paglia, DPM, Andrew M Abramowitz, Andrew R Wasko, Anh M Lac, Anissa M Vargas, Ann B Okon, Anthony A Charity, Anthony J Grace, Arduino Frankovic, Arnold Seo, PhD, Arthur G Hurst, Audrey J Yarbrough, Azza Talaat, Barbara J Rincon, Benton M Ketron, Betsy C Galliher, Blondell W Johnson, Bonnie L Fry, Bonnie L Menzel, Brandy N Lepage, Bruce G Cooper, Byungja E Marciante, Camille D Brown, Carmen Y Fisher, Charles D Brown, Charles R Bonapace, PhD, Cheron M Portee, Christopher D Rush, Christopher J Smith, Christopher S Fields, Clinton V Giustra, Crystal A Branch, Cynthia A Harris, MD, RN, Daniel J Lahar, Daniel L Aisen, David A Carlson, David M Beltran, David M Mcnew, David R Lattuca, Dawn C Olenjack, Denise L Burosh, Diamond M Oden, Diane E Bruce, Dipesh K Shah, Donald J Ullstrom, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Elisa M Fleming, Elizabeth D Connell, Elizabeth H Davis, Elizabeth H Slazak, Erin L Nagel, Farhana Khan, Felix Maldonado, Gabriel Davila, Gajendiran Mahadevan, PhD, Gary T Greco, Gene R Gunn, George C Amedro, Gulshan R Anand, Habacuc V Barrera, Hamet M Toure, PharmD MPH, Harry J Brewer, Hilary K Wagner, Hugh M Mcclure, II, Ingrid A Zambrana, Iram R Hassan, PhD, Irina Gaberman, Iris C Macinnes, Jackson Y See, James D Bridges, James M Kewley, Jane C Chen, Janete F Guardia, Janice M Hickok, Jasmine Y Wang, Jay B Shah, Jay T Wong, Jeanette L Mcginnis, Jennifer J Edmiston, Joel D Martinez, Joel R Merriman, Jogy George, John A Gonzalez, John A Podsadowski, John P Shelton, Jonathan D Green, Joseph A Famiglietti, Joseph J Vannelli, Joshua C Schafer, Joshua D Lopez, Joy P Matthias, Joyce A Williams, Judy Keihl, Julie Scoma, Kara A Scheibner, PhD, Karen L Kosar, Kathleen Chmura Shaffer, Kathryn A Nagy, Kathryn Suttling, Kelly N Kerr, Kenneth G Klobus, Kent C Faul, Kerun Hardeo, Kham Phommachanh, Kim M Downing, Kimberley A Ricketts, Kimberly Y Smithson, Kyle J Spencer, Ladislav Kermet, Lance Mde Souza, MBA, Lata C Mathew, PhD, Latorie S Jones, Laura E Garcia, Lauren E Blaser, LCDR Chad N Thompson, Leighton Kn Gai, Leon L Crawley, Li Hongpaul Yeh, PhD, Linda Galindo, Linda M Moore, Linda M Sacco, Lisa A Doyle, Lourdes Andujar, Madushini Dharmasena, PhD, Makini Cobourne Duval, PhD, Marc S Neubauer, Margaret E Sarles, Margaret M Annes, Marijo B Kambere, PhD, Marilyn S Babu, Marlene L Davis, Martin K Yau, PhD, Mary Alice B Garlipp, Mary M Finn, Marybeth Willis, Matthew C Watson, Matthew D Schnittker, Melissa N Gregorio, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael F Skelly, PhD, Michael G Sinkevich, Michael R Dominick, Michael W Burd, Michelle J Hines, Michelle M Noe Varga, Mindy M Chou, Mohsen Rajabi Abhari, FDA, Morris Paul, Mra Davism, Mra Narulaa, Muralidhara B Gavini, PhD, Nancy A Bellamy, Nancy G Schmidt, Nancy M Espinal, Nasser Yazdani, DVM, MPH, Nicholas C Mendiola, Nicholas L Paulin, Omadevi Somai, Investigator, Pamela L Velez Vega, Pankaj H Amin, Parul M Patel, Patricia H Dlugosz, Paul A Bonneau, Paul Mouris, Pauline N Logan, Peter M Trunk, Philip M Steele, PhD, Phillip Angart, PhD, Phillip D Waldron, Randi Lynn Bodoh, Richard K Glabach, Richard W Berning, Robert C Steyert, Robert J Veitch, Roberto A Dookhan, Robin R Waller, Robles, Ruben C Ayala, PharmD, Russ E Davis, Ruth E Medcalf, Sabine Francke, Sajin Bae, Samantha J Pinizzotto, D V M, Sarah Forney, Sasha M Latonis, Scott B Laufenberg, Scott T Ballard, Seongeun Cho (Julia), PhD, Shannon A Dinardo, Shirley H Isbill, Simone E Pitts, Sony Mathews, Sripal R Mada, PhD, Stacey F Rivette, Stefanie R Cook, Stephen L Beekman, Steven E Bowen, PhD, Steven J Libal, Stuart W Russell, Syeda N Mahazabin, Tammy S Notto, Tara K Carmody, Tara K Normandin, Terrance L Thomas, Terri E Gibson, Theressa B Smith, Thomas L Bellonte, Thomas P Hansen, Thomas W Gordon, Travis M Beard, Tricia S Martinez, Tyanna N Hadley, Vickie J Kanion, Wendy M Stone, William P Chilton, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yiying E Chen, Yiyue Zhang (nmi), PhD

Joanne M Schlossin's Documents

Publish Date Document Type Title
April, 2024 FDA 483 Yaohan Lam, M.D. - Form 483, 2024-04-12
November, 2016 EIR Regeneron Pharmaceuticals Inc - EIR, 2016-11-30
March, 2022 FDA 483 HMS Veterinary Development Inc - Form 483, 2022-03-17
March, 2019 FDA 483 Wuxi Apptec Suzhou Co.,Ltd - Form 483, 2019-03-08
August, 2018 EIR ICON Development Solutions, LLC - EIR, 2018-08-30
January, 2019 FDA 483 Monica Bhatia, MD - Form 483, 2019-01-31
March, 2019 FDA 483 JOINN Laboratories (Suzhou) - Form 483, 2019-03-15
September, 2022 FDA 483 Tyrone McCall, M.D. - Form 483, 2022-09-19
August, 2019 FDA 483 XGen Pharmaceuticals DJB, Inc. - Form 483, 2019-09-09
March, 2013 FDA 483 Slovin, Susan M.D., Ph.D. - Form 483, 2013-03-21
November, 2023 FDA 483 Parvez Mantry - Form 483, 2023-11-14
March, 2017 EIR Eytan M. Stein, M.D. - EIR, 2017-03-16
December, 2016 EIR Reisdorf Bros Inc. - EIR, 2016-12-28
September, 2021 FDA 483 Mohammed Ansari - Form 483, 2021-09-16
March, 2013 EIR Slovin, Susan M.D., Ph.D. - EIR, 2013-03-21
November, 2018 FDA 483 Memorial Sloan Kettering Cancer Center - Form 483, 2018-11-09
October, 2020 FDA 483 James S. Cochran, MD - Form 483, 2020-10-29
June, 2012 FDA 483 Michael E. Pichichero, M.D. - Form 483, 2012-06-29
November, 2014 EIR Peter Pruim - EIR, 2014-11-07
February, 2023 FDA 483 Scott R. Bartley, M.D. - Form 483, 2023-02-17
July, 2012 EIR Majed Refaai, M.D - EIR, 2012-07-31
March, 2023 FDA 483 Brian Flowers - Form 483, 2023-03-23
August, 2022 FDA 483 Murtaza Mussaji, D.O.. - Form 483, 2022-08-16
February, 2024 FDA 483 Daniel Carrasco, M.D. - Form 483, 2024-02-28
May, 2024 FDA 483 Texas Biomedical Research Institute - Form 483, 2024-05-17
August, 2024 FDA 483 Sanober Kable, M.D. - Form 483, 2024-08-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more